Researchers recruit luminescent nanoparticles to image brain function
News Nov 18, 2015
Research biologists, chemists, and theoreticians at the U.S. Naval Research Laboratory (NRL) are on pace to develop the next generation of functional materials that could enable the mapping of the complex neural connections in the brain. The ultimate goal is to better understand how the billions of neurons in the brain communicate with one another during normal brain function or dysfunction as result of injury or disease.
"There is tremendous interest in mapping all the neuron connections in the human brain," said Dr. James Delehanty, research biologist, Center for Biomolecular Science and Engineering. "To do that we need new tools or materials that allow us to see how large groups of neurons communicate with one another while, at the same time, being able to focus in on a single neuron's activity. Our most recent work potentially opens the integration of voltage-sensitive nanomaterials into live cells and tissues in a variety of configurations to achieve real-time imaging capabilities not currently possible."
The basis of neuron communication is the time-dependent modulation of the strength of the electric field that is maintained across the cell's plasma membrane. This is called an action potential. Among the nanomaterials under consideration for application in neuronal action potential imaging are quantum dots (QDs)—crystalline semiconductor nanomaterials possessing a number of advantageous photophysical attributes.
"QDs are very bright and photostable so you can look at them for long times and they allow for tissue imaging configurations that are not compatible with current materials, for example, organic dyes," Delehanty added. "Equally important, we've shown here that QD brightness tracks, with very high fidelity, the time-resolved electric field strength changes that occur when a neuron undergoes an action potential. Their nanoscale size make them ideal nanoscale voltage sensing materials for interfacing with neurons and other electrically active cells for voltage sensing."
QDs are small, bright, photo-stable materials that possess nanosecond fluorescence lifetimes. They can be localized within or on cellular plasma membranes and have low cytotoxicity when interfaced with experimental brain systems. Additionally, QDs possess two-photon action cross-section orders of magnitude larger than organic dyes or fluorescent proteins. Two-photon imaging is the preferred imaging modality for imaging deep (millimeters) into the brain and other tissues of the body.
In their most recent work, the NRL researchers showed that an electric field typical of those found in neuronal membranes results in suppression of the QD photoluminescence (PL) and, for the first time, that QD PL is able to track the action potential profile of a firing neuron with millisecond time resolution. This effect is shown to be connected with electric-field-driven QD ionization and consequent QD PL quenching, in contradiction with conventional wisdom that suppression of the QD PL is attributable to the quantum confined Stark effect—the shifting and splitting of spectral lines of atoms and molecules due to presence of an external electric field.
"The inherent superior photostability properties of QDs coupled with their voltage sensitivity could prove advantageous to long-term imaging capabilities that are not currently attainable using traditional organic voltage sensitive dyes," Delehanty said. "We anticipate that continued research will facilitate the rational design and synthesis of voltage-sensitive QD probes that can be integrated in a variety of imaging configurations for the robust functional imaging and sensing of electrically active cells."
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Rowland CE et al. Electric Field Modulation of Semiconductor Quantum Dot Photoluminescence: Insights Into the Design of Robust Voltage-Sensitive Cellular Imaging Probes. Nano Letters, Published Online September 28 2015. doi: 10.1021/acs.nanolett.5b02725
Researchers have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.
A new study of cells called pericytes in a mouse model of the human brain have suggested that they play a previously unknown role in brain health. Pericytes secrete a substance that keeps neurons alive, even in the presence of leaky blood vessels that foul brain matter and result in cognitive decline.READ MORE